PROCEPT BioRobotics® to Report First Quarter 2026 Financial Results on April 29, 2026

Rhea-AI Summary

PROCEPT BioRobotics (Nasdaq: PRCT) will report first quarter 2026 financial results after market close on April 29, 2026. Management will host a conference call at 4:30 p.m. Eastern Time the same day.

Webcast and dial-in registration links are provided for investors and analysts, live audio will be available on the company investor website, and an archived recording will remain available for at least 90 days.

News Market Reaction – PRCT

-0.30%

1 alert

-0.30% Session close to close

$1.31B Market Cap

0.0x Rel. Volume

In the Apr 10 session, PRCT declined 0.30%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN JOSE, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics^® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the first quarter of 2026 after market close on Wednesday, April 29, 2026. The Company’s management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.

Investors interested in listening to the conference call may do so by following one of the below links:

• Webcast link for interested listeners:
  • https://edge.media-server.com/mmc/p/rdtftqik/
    
    
• Dial-in registration for sell-side research analysts:
  • https://register-conf.media-server.com/register/BIac4b002880274c7086f519f21b93cd1f
    
    

Live audio of the webcast will be available on the “Investors” section of the Company’s website at: https://ir.procept-biorobotics.com.

An archived recording will be available on the “Investors” section of the Company’s website at: https://ir.procept-biorobotics.com. Each webcast will be available for replay for at least 90 days after the event.

About PROCEPT BioRobotics Corporation
PROCEPT BioRobotics is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. PROCEPT BioRobotics manufactures the AQUABEAM^® and HYDROS^® Robotic Systems. The HYDROS Robotic System is the only AI-powered, robotic technology that delivers Aquablation therapy. PROCEPT BioRobotics designed Aquablation therapy to deliver effective, safe, and durable outcomes for males suffering from lower urinary tract symptoms or LUTS, due to BPH that are independent of prostate size and shape or surgeon experience. BPH is the most common prostate disease and impacts approximately 40 million men in the United States. The Company has developed a significant and growing body of clinical evidence with approximately 250 peer-reviewed publications, supporting the benefits and clinical advantages of Aquablation therapy.

Investor Contact:
Matt Bacso
VP, Investor Relations and Business Operations
m.bacso@PROCEPT-BioRobotics.com

FAQ

When will PROCEPT BioRobotics (PRCT) report Q1 2026 results?

PROCEPT BioRobotics will report Q1 2026 results after market close on April 29, 2026. According to the company, results will be released after market close and management will host a conference call that same day to discuss the announcement and answer investor questions.

What time is the PROCEPT BioRobotics (PRCT) conference call on April 29, 2026?

The conference call is scheduled for 4:30 p.m. Eastern Time on April 29, 2026. According to the company, management will present on the call and provide access details via webcast and dial-in registration for investors and sell-side analysts.

How can investors access the PROCEPT BioRobotics (PRCT) webcast for the Q1 2026 results?

Investors can access the live webcast via the company’s Investors website and a provided media-server link. According to the company, live audio will stream on the investor relations site and an archived recording will be available for replay for at least 90 days.

Will PROCEPT BioRobotics (PRCT) provide a replay of the Q1 2026 results webcast?

Yes, an archived replay will be available for at least 90 days after the event. According to the company, the archived recording will be posted in the Investors section of its website for on-demand listening by investors and analysts.

Is there a registration required for sell-side analysts to join the PROCEPT BioRobotics (PRCT) call?

Sell-side analysts are asked to register using the provided dial-in registration link before the call. According to the company, a separate registration link is available specifically for sell-side research analysts to gain dial-in access.

Where will PROCEPT BioRobotics post investor materials related to the Q1 2026 results (PRCT)?

Investor materials and live audio will be posted on the company’s Investors website at its IR page. According to the company, both the live webcast and the archived recording will be accessible from the Investors section for at least 90 days.